MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Developing a Framework for Huntington’s Disease Care Partner Training and Support – HD Care Partner Bootcamp Series

    J. Yomtoob, E. Zivin, K. Fagan, D. Bega (Chicago, USA)

    Objective: In this protocol we present a novel collaborative framework for a Huntington’s Disease (HD) Care Partner (CP) bootcamp series designed to train and support…
  • 2025 International Congress

    Clinical and Genetic spectrum of Developmental dyskinetic encephalopathy – Experience from a Tertiary care centre

    A. Vijayaraghavan, S. Nair, S. Sundaram (Thiruvananthapuram, India)

    Objective: To provide unique data on the clinical and genetic spectrum of developmental dyskinetic encephalopathies. Background: Developmental dyskinetic encephalopathy(DDE) is a recently described clinically and…
  • 2025 International Congress

    A Multidomain Fall Prevention Program: Perspectives of People with Parkinson’s Disease and their Care Partners

    L. Goh, A. Darmali, C. Koch, S. Tran, S. Paul, C. Canning, S. Edwards, S. Harkness, R. Savage, L. Webster, G. Zelma, N. Allen (Camperdown, Australia)

    Objective: To explore the acceptability of a multidomain fall prevention program (Integrate) for people with Parkinson’s disease (PwP) and their care-partners, and factors that influenced…
  • 2025 International Congress

    Quantitative evaluation of speech characteristics in Assessment of Motor Speech for Dysarthria (AMSD) using acoustic analysis

    R. Kotani, Y. Shirota, A. Seto, Y. Nagashima, H. Onodera, K. Yatani, M. Hamada, T. Toda (Tokyo, Japan)

    Objective: This study aims to extract acoustic features from speech data obtained from patients undergoing the Assessment of Motor Speech for Dysarthria (AMSD), a clinical…
  • 2025 International Congress

    Sleep Quality among Lewy Body Dementia Family Caregivers

    W. Ayele, J. Hemm, S. Mitchell Chen, E. Stevens, A. Taylor, K. Fargo, D. Mariani, S. Seshadri, C. Bentley, T. Manak, A. Miller, C. Pensyl, C. Pierce, M. Voss, B. Ouyang, J. Chodosh, J. Fleisher (Chicago, USA)

    Objective: To explore the relationship between caregiver sleep quality and caregiver and care recipient characteristics in Lewy Body Dementia (LBD). Background: LBD family caregivers have…
  • 2025 International Congress

    Spinocerebellar Ataxia Type 40 (SCA-40) with a Novel Mutation in an Indian Female: A Case Report

    A. Mehta, P. Hiremath, M. Javali, P. R, L. Priya, P. Acharya (Bengaluru, India)

    Objective: To report the first Indian patient with SCA 40 who presented in the fifth decade with a novel missense mutation (c.1291C>T, p.His431Tyr), expanding the…
  • 2025 International Congress

    Prevalence and Comorbidities of Orthostatic Hypotension in Older Adults: A Two-Year Study

    ANA. Ovchynnykova, Y. Trufanov (Kyiv, Ukraine)

    Objective: To determine the prevalence of OH and its associations with autonomic dysfunction, falls, and mortality. Background: Orthostatic hypotension (OH) is a common problem that…
  • 2025 International Congress

    A VUS and the Value of a Biomarker in Ataxia with Oculomotor Apraxia Type 2

    F. Brito, A. Guerra, R. Kauark, G. Nunes, M. Vassoler, F. Nascimento, C. Nascimento, G. Piñeiro, . (Salvador, Brazil)

    Objective: Objective: To demonstrate the importance of serum biomarkers, such as alpha-fetoprotein (AFP), in the diagnostic evaluation of Ataxia with Oculomotor Apraxia Type 2 (AOA2).…
  • 2025 International Congress

    A Comprehensive Exploration of the Quality of Life and Caregiver Burden in Multiple System Atrophy

    I. Karagoz, H. Morris, H. Houlden, V. Chelban (London, United Kingdom)

    Objective: To evaluate the impact of MSA disease on QoL and caregiver burden and identify influencing factors of QoL in a large UK-based cohort Background:…
  • 2025 International Congress

    Using Zebrafish Model to Investigate Complex Hereditary Spastic Paraplegia Caused by EPT1 Variants

    S. Wang, S. Banka, M. Lowe, A. Nicolaou (Manchester, United Kingdom)

    Objective: To generate disease-representative zebrafish models using CRISPR-Cas9 technique.To characterise the zebrafish models by performing phenotypic characterization, neurobiological experiments, lipidomic and RNASeq studies.To test targeted…
  • « Previous Page
  • 1
  • …
  • 115
  • 116
  • 117
  • 118
  • 119
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley